http://www.usdoj.gov/dea/concern/methylphenidate.html
Methylphenidate
Methylphenidate, a Schedule II substance, has a high potential for abuse and
produces many of the same effects as cocaine or the amphetamines. The abuse of
this substance has been documented among narcotic addicts who dissolve the
tablets in water and inject the mixture. Complications arising from this
practice are common due to the insoluble fillers used in the tablets. When
injected, these materials block small blood vessels, causing serious damage to
the lungs and retina of the eye. Binge use, psychotic episodes, cardiovascular
complications, and severe psychological addiction have all been associated with
methylphenidate abuse.
Methylphenidate is used legitimately in the treatment of excessive daytime
sleepiness associated with narcolepsy, as is the newly marketed Schedule IV
stimulant, modafinil (Provigil®). However; the primary legitimate medical use
of methylphenidate (Ritalin®, Methylin®, Concerta®) is to treat attention
deficit hyperactivity disorder (ADHD) in children. The increased use of this
substance for the treatment of ADHD has paralleled an increase in its abuse
among adolescents and young adults who crush these tablets and snort the powder
to get high. Youngsters have little difficulty obtaining methylphenidate from
classmates or friends who have been prescribed it. Greater efforts to safeguard
this medication at home and school are needed.
http://www.saferchild.org/adhddebate.htm
New trend in marketing prescription drugs to parents: A new trend in
medications for attention-deficit disorder is to market them to parents in
several popular parenting and women's magazines. It's logical to assume, then,
that the drug manufacturers believe it's the parents who make the decisions
about which ADHD medications their children should be taking. We're greatly
concerned about this trend and wonder if it best suits a child's interests and
medical needs. Reportedly, the U.S. Drug Enforcement Administration also is
concerned about the advertisements and is moving to limit such advertising.